Nolu Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: Flat-rate GLP-1 with both oral and injectable options, named pharmacy partners
Nolu scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Nolu (Nolu LLC) is a direct-to-consumer telehealth platform offering compounded GLP-1 weight-loss treatment after an online intake reviewed by a licensed clinician. It sells injectable semaglutide ($199), injectable tirzepatide ($279) and a once-daily oral semaglutide tablet ($239), each billed every 4 weeks at the same price at every dose, with longer plans costing less per cycle. Prices include the consultation, medication and shipping, and the company names four partner pharmacies.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Nolu
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Nolu at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Oral Semaglutide
- Starting price
- $199/4 wks (billed per 4 weeks)
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Consult · Medication · Shipping
- FDA status
- No FDA warning letter on record
How we scored Nolu
Each dimension is scored algorithmically from Nolu’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.9/10At $199/mo (per 4 weeks), Nolu runs about 9% above the $182 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.9/10Nolu offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.5/10Online intake and platform experience (ongoing clinician messaging, consult included in the price); 8 platform features disclosed.
Trust & Safety15%
7.7/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy.
Accessibility10%
6.2/10Nolu's exact state footprint isn't published. Confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
6.1/10Clinician messaging between visits.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Nolu review
Last checked October 2026- Confirmed current pricing across 3 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $199–$279/mo across 3 dose/plan tiers (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Nolu
We walked Nolu’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1The /weight-loss page lists Semaglutide $199, Tirzepatide $279 and Oral Semaglutide $239, each labeled every 4 weeks, cancel anytime
- 2Clicking Get started opens a goal picker: Weight Loss, Microdose, Longevity or Men's Health
- 3Selecting Weight Loss routes to Nolu's intake app
- 4The first intake screen asks for current height and weight
- Prices have dropped: semaglutide from $249 to $199, tirzepatide from $339 to $279 and oral semaglutide from $279 to $239, all still per 4 weeks
- The every-4-weeks cadence is printed on each price card rather than hidden until checkout
- The FAQ says longer plans cost less per cycle, down to $137, but the plan options and their prices are not shown on the public site
- The intake now opens with height and weight instead of the name, phone and email screen it used to start with
- The footer's Telehealth Consent link goes to OpenLoop Health's consent page, which suggests the clinician network runs through OpenLoop Health
- A separate Microdose line (low-dose GLP-1 with B12 or NAD+) is sold at $179 every 4 weeks, without naming the GLP-1 drug
- Whether a video visit or labs are required is not shown before the intake's first health question
Nolu customer support
GLP-1 medications Nolu offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
$199 every 4 weeks (13 charges a year), same price at every dose. Longer plans cost less per cycle, down to $137.
$279 every 4 weeks (13 charges a year), same price at every dose. Longer plans cost less per cycle.
$239 every 4 weeks, on a separate oral-tablet plan from injectable semaglutide.
Ready to get started?
Plans and promotions change often, so check Nolu's current pricing and active discounts before you decide.
What we like
- Price includes consultation, medication and shipping, with no membership fee on top
- Flat pricing: the same price at every dose as you titrate up
- Names four contracted partner pharmacies in its Terms of Service
- Prices ($199 to $279 per 4 weeks) are shown before you start the intake
- Oral (daily tablet) and injectable semaglutide both offered, plus tirzepatide
- No long-term contract; pause or cancel from your dashboard, with 72 hours' notice before the next charge
- FSA/HSA eligible and free expedited shipping on every order
Watch-outs
- Billed every 4 weeks, not monthly, so you pay 13 times a year, though the site says so upfront
- No LegitScript or PCAB certification found for the company or its named pharmacies
- No Trustpilot, Google or BBB rating displayed to back up service quality
- Cheaper longer plans are advertised, but their exact prices are not shown before you start the intake
- State availability is a blanket all 50 states plus DC claim with no per-state list
- Plans billed one cycle at a time get no refund for the cancellation month or any prior month
- Does not accept insurance; cash-pay only
Is Nolu worth it?
What Nolu is selling, in one line, is Flat-rate GLP-1 with both oral and injectable options, named pharmacy partners. It runs $199/month (per 4 weeks) at every dose; there's no clean category median to weigh that against, but it's a published number rather than one you find out only after signing up. Its standout is a needle-free oral option for people who would rather not inject.
Beyond the medication itself, Nolu takes HSA/FSA payment. It also charges the same price at every dose and offers round-the-clock messaging.
How much Nolu costs
Compounded semaglutide runs $199–$239/month depending on plan, the low end listed as “per 4 weeks”, and compounded tirzepatide runs $279/month (per 4 weeks).
Because Nolu's headline figure is listed as “per 4 weeks”, we don't set it against the roughly $182 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare Nolu with the month-to-month prices of the alternatives below instead.
Belle Health (about $199/month) is one of the closest alternatives to weigh Nolu against.
Medications: what Nolu prescribes
Nolu prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the pair backed by the largest published weight-loss trials. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy, which is why the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Nolu's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral, sublingual and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who Nolu is best for, and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
- value being able to message a clinician between visits instead of waiting on the next scheduled one.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
Nolu offers clinician messaging between visits, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Nolu is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
The Bottom Line
Nolu scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Nolu?
From $199/4 wks (billed per 4 weeks). See current pricing and start your free consultation.
Nolu might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Nolu vs…
Nolu scores7.2/10
Side-by-side pricing, medications and scores. Pick a matchup.
Nolu vs Amazon One Medical
Amazon One Medical scores 8.5/10
Nolu vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Nolu review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Nolu's current pricing
Plans from $199/4 wks (billed per 4 weeks). Start your free consultation to check eligibility and today's price.